The China biopsy devices market is expected to grow up to about US$ 1.13 billion by 2033 from about US$ 612.62 million in 2024 at a compound annual growth rate (CAGR) of 7.06% during 2025-2033. This is due to increasing cancer prevalence, the demand for minimally invasive diagnostic procedures, advancements in biopsy technologies, and the increasing healthcare investments in the region.
In China, biopsy devices are extensively used in diagnosing cancer, a growing health concern due to lifestyle changes, aging population, and environmental factors. They are also utilized in diagnosing other conditions, such as inflammatory diseases and infections. With advancements in technology, devices like ultrasound-guided and robotic-assisted biopsy systems have become more accessible, ensuring higher accuracy and patient comfort. China’s increasing focus on early disease detection, supported by growing healthcare infrastructure and government initiatives, has boosted the adoption of biopsy devices across hospitals and diagnostic centers nationwide.
China Biopsy Devices Industry Overview
Biopsy devices are specialized medical tools used to extract tissue samples from the body for diagnostic examination, particularly for detecting and analyzing diseases like cancer. These devices include needle-based instruments, biopsy guns, forceps, and vacuum-assisted systems, which allow precise and minimally invasive sampling of tissues from various organs. The samples are then analyzed in a laboratory to identify abnormalities, determine disease progression, or evaluate treatment effectiveness.In China, biopsy devices are extensively used in diagnosing cancer, a growing health concern due to lifestyle changes, aging population, and environmental factors. They are also utilized in diagnosing other conditions, such as inflammatory diseases and infections. With advancements in technology, devices like ultrasound-guided and robotic-assisted biopsy systems have become more accessible, ensuring higher accuracy and patient comfort. China’s increasing focus on early disease detection, supported by growing healthcare infrastructure and government initiatives, has boosted the adoption of biopsy devices across hospitals and diagnostic centers nationwide.
Growth Drivers for the China Biopsy Devices Market
Rising Prevalence of Cancer
The rising prevalence of cancer in China, attributed to factors such as shifting lifestyles, an aging population, and various environmental influences, has created a substantial surge in the demand for biopsy devices. The importance of early detection cannot be overstated, as it plays a vital role in increasing the likelihood of successful treatment outcomes. This pressing need is propelling healthcare facilities to embrace advanced diagnostic tools, ensuring that they are equipped to provide timely and accurate assessments for patients facing this formidable disease. In 2022, China experienced an estimated 4,824,700 new cancer cases and 2,574,200 cancer-related deaths. The most common types of cancer identified were lung, colon-rectum, thyroid, liver, and stomach cancers, which together represented 57.42% of all new cases diagnosed.Technological Advancements in Biopsy Devices
Recent advancements in biopsy technologies have revolutionized the way diagnostic procedures are performed. Innovations such as ultrasound-guided systems enable clinicians to obtain tissue samples with enhanced precision, ensuring minimal discomfort for patients. The robotic-assisted devices also make it easy to streamline biopsy procedures for greater accuracy and control during procedures. The minimally invasive techniques are helping cut down on much recovery time, improving the patient experience. These cutting-edge advances are now driving a notable expansion in the biopsy devices market in China as providers seek sophisticated and reliable solutions to meet growing demands for accurate diagnostics. As such, this innovation in biopsy technology is bringing the world into a new horizon in medical diagnostics that ensures comfort to patients while offering results that are as accurate as possible. Mar 2024, Intuitive Surgical gains China regulatory approvals to sell Ion surgical robot system.Expansion of Health Care Infrastructure
Continuing effort of China in improving health infrastructure and aggressive steps taken by the government to improve its diagnostic abilities makes this country a forerunner in medical science. Building high-tech diagnostic centers, ultra-modern hospitals, and cancer treatment centers would add accessibility to people of healthcare services. This growth ensures high-tech biopsy technology is not just available in all the bustling metros but also found in the least populated rural localities, spreading the reach much more and therefore helping improve results for patients across wide populations. In September 2024, China's Ministry of Commerce and health bodies announced a move that allows all foreign-owned hospitals in big cities such as Beijing and Shanghai and eased restrictions put on foreign direct investment in healthcare institutions.Challenges in the China Biopsy Devices Market
High Costs of Advanced Biopsy Devices
The substantial expenses linked to advanced biopsy technologies present a significant obstacle to their widespread adoption, particularly in underdeveloped regions. Many healthcare facilities struggle with budget constraints, which restrict their capacity to invest in these state-of-the-art biopsy devices. As a result, the promise of improved diagnostic precision and patient outcomes is often out of reach for many medical institutions, limiting access to essential healthcare advancements in areas that need them the most.Limited Skilled Professionals
One of the biggest challenges in the health care landscape is the scarcity of highly trained medical professionals who possess the expertise to operate sophisticated biopsy devices and accurately interpret the resulting data. This is a challenge that is most pronounced in rural and less-developed regions of China, where access to such advanced technologies is already limited. Consequently, this skills gap severely undermines the effective utilization of biopsy technologies, preventing these communities from benefiting fully from potentially life-saving diagnostics and treatments.China Needle-Based Guns Biopsy Devices Market
The Chinese market for needle-based guns biopsy devices is witnessing tremendous growth. This is primarily because these are minimally invasive devices and offer high precision for the acquisition of tissue samples. Advanced devices have become increasingly popular for the detection and diagnosis of several cancers, especially in critical organs such as the liver, lungs, and breasts. As awareness of early cancer detection increases, there is a significant increase in their use within hospitals and diagnostic centers across the country, which indicates a shift towards more efficient and patient-friendly medical procedures. This trend is expected to enhance diagnostic capabilities and improve patient outcomes significantly.China Breast Biopsy Devices Market
The Chinese market is highly growing because of the increasingly prevalent breast cancer incidence and its heightened awareness as regards the critical need for an early diagnosis. Vacuum-assisted biopsy systems as well as the core needle biopsy tools from different medical appliances are becoming prominent in clinical care. These are complemented by the new advancements in imaging technology that help achieve precise and reliable diagnosis. And because awareness will keep increasing, these new innovative biopsy solutions are sure to attract greater demand with more precise diagnoses and improved outcomes in the treatment of breast cancer. February 2024: Hologic rolled out its Selenia Dimensions 3D Mammography System for better detection of breast cancer, employing advanced biopsy technology to ensure that the tissue is sampled in an accurate and enhanced imaging way.China Lung Biopsy Devices Market
Lung biopsy devices market in China is growing rapidly because of alarming rises in lung cancer cases caused by environmental pollution and smoking habits. With the country's air quality issues and the high prevalence of tobacco use, the need for accurate and timely diagnosis has never been more critical. Advanced imaging-guided biopsy techniques, particularly CT-guided systems, are playing a pivotal role in this landscape. These sophisticated methods improve the precision of diagnoses, allowing healthcare professionals to obtain tissue samples with greater accuracy. This has led to the market of these innovative biopsy devices to experience significant growth, fueled by the dire need for proper cancer detection and management.China CT Scan Biopsy Devices Market
The CT scan biopsy devices market in China is growing rapidly, driven by the increasing dependence on CT-guided biopsies for their remarkable accuracy in diagnosing deep-seated lesions. These advanced devices are crucial in the early detection and diagnosis of various types of cancers and other medical abnormalities. They enhance diagnostic accuracy by providing detailed imaging and precise targeting while prioritizing patient safety throughout the procedure. As healthcare professionals continue to adopt these technologies, the impact on patient outcomes and the overall efficiency of diagnostic processes is becoming increasingly evident.China MRI-Guided Biopsy Devices Market
The MRI-guided biopsy devices market in China is seeing a steep growth curve because of the high resolution imaging MRI technology offers. Innovative devices have started to find use in complicated medical cases being diagnosed, particularly soft tissues in the brain and breast. In doing so, by using MRI with its superior details and accuracy, it is possible for healthcare professionals to gather precise insight, which significantly increases diagnostic outcomes. This improvement in imaging quality not only helps in performing biopsies more effectively but also enables the detection of subtle abnormalities, which may otherwise go unnoticed using other imaging techniques. Consequently, MRI-guided biopsy devices are increasingly being used and demand is rising to reflect their significant role in enhancing patient care and the decision-making process.China Biopsy Devices Diagnostic & Imaging Center Market
Diagnostic and imaging centers in China are essential contributors to the growth of the biopsy devices market. These facilities are equipped with cutting-edge imaging technologies and staffed by highly trained professionals, allowing them to address the increasing demand for early and accurate diagnoses. Their expertise and advanced tools facilitate the widespread adoption of biopsy devices throughout the country, ensuring that patients receive timely and precise medical evaluations. As a result, these centers are critical in enhancing the quality of healthcare as a whole and improving patient outcomes in China.China Biopsy Devices Market Segments
Product - Market breakup by 5 viewpoints:
- Needle-Based Guns
- Biopsy Guidance Systems
- Biopsy Needles
- Biopsy Forceps
- Others
Application - Market breakup by 6 viewpoints:
- Breast Biopsy
- Lung Biopsy
- Prostate Biopsy
- Liver Biopsy
- Gastroenterology Biopsy
- Others
Technology - Market breakup by 5 viewpoints:
- CT Scan
- Stereotactic Guided
- Ultrasound Guided
- MRI Guided
- Others
End-User - Market breakup by 3 viewpoints:
- Hospitals
- Diagnostic & Imaging Center
- Others
Company Analysis: Overview, Recent Development, Revenue Analysis
- Cardinal Health, Inc.
- Hologic, Inc.
- Danaher Corporation
- Becton, Dickinson and Company
- Boston Scientific Corporation
- Medtronic plc.
- Olympus Corporation
- CONMED Corporation
Table of Contents
1. Introduction2. Research Methodology3. Executive Summary5. China Biopsy Device Market
4. Market Dynamics
6. Market Share
7. Product
8. Imaging Technology
9. End User
10. Porter's Five Forces Analysis
11. SWOT Analysis
12. Key Players Analysis
Companies Mentioned
- Cardinal Health, Inc.
- Hologic, Inc.
- Danaher Corporation
- Becton, Dickinson and Company
- Boston Scientific Corporation
- Medtronic plc.
- Olympus Corporation
- CONMED Corporation
Methodology
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | March 2025 |
| Forecast Period | 2024 - 2033 |
| Estimated Market Value ( USD | $ 612.62 Million |
| Forecasted Market Value ( USD | $ 1130 Million |
| Compound Annual Growth Rate | 7.0% |
| Regions Covered | China |
| No. of Companies Mentioned | 8 |
